DongKook Pharmaceutical Co., Ltd.

Informe acción KOSDAQ:A086450

Capitalización de mercado: ₩797.0b

Salud financiera de hoja de balance de DongKook Pharmaceutical

Salud financiera controles de criterios 6/6

DongKook Pharmaceutical tiene un patrimonio de accionistas total de ₩604.2B y una deuda total de ₩72.7B, lo que sitúa su ratio deuda-patrimonio en 12%. Sus activos y pasivos totales son ₩839.5B y ₩235.3B respectivamente. El BAIT de DongKook Pharmaceutical es de ₩66.9B, por lo que su ratio de cobertura de intereses es de 109.7. Tiene efectivo e inversiones a corto plazo que ascienden a ₩94.2B.

Información clave

10.3%

Ratio deuda-patrimonio

₩63.46b

Deuda

Ratio de cobertura de intereses-136.3x
Efectivo₩88.58b
Patrimonio₩615.88b
Total pasivo₩250.50b
Activos totales₩866.38b

Actualizaciones recientes sobre salud financiera

Recent updates

These 4 Measures Indicate That DongKook Pharmaceutical (KOSDAQ:086450) Is Using Debt Reasonably Well

May 29
These 4 Measures Indicate That DongKook Pharmaceutical (KOSDAQ:086450) Is Using Debt Reasonably Well

We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt

May 06
We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 06
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why

How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?

Mar 15
How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?

The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?

Feb 28
The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?

DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?

Feb 14
DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?

DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly

Feb 01
DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jan 19
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate

The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio

Jan 06
The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting

Dec 21
With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting

What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?

Dec 08
What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?

The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It

Nov 23
The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₩419.2B) de A086450 superan a sus pasivos a corto plazo (₩203.1B).

Pasivo a largo plazo: Los activos a corto plazo de A086450 (₩419.2B) superan a sus pasivos a largo plazo (₩32.2B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: A086450 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de A086450 ha pasado de 16.7% a 12% en los últimos 5 años.

Cobertura de la deuda: La deuda de A086450 está bien cubierta por el flujo de caja operativo (57.5%).

Cobertura de intereses: A086450 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.


Hoja de balance


Descubre empresas con salud financiera